AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,026.00p
   
  • Change Today:
    674.00p
  • 52 Week High: 12,096.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 4,120,393
  • Market Cap: £186,430m
  • RiskGrade: 123

Latest ShareCast News

London close: Stocks finish mixed as US GDP growth slows

By Josh White

Date: Thursday 25 Apr 2024

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

AstraZeneca ShareCast News

AstraZeneca blows past analysts' estimates for Q1 25-Apr-2024 ShareCast
London close: Stocks finish lower as ECB stands ... 11-Apr-2024 ShareCast
AstraZeneca to hike 2024 dividend by 7% 11-Apr-2024 ShareCast
AstraZeneca's Enhurtu cancer gets US green light... 08-Apr-2024 ShareCast
AstraZeneca announces positive lung cancer treat... 05-Apr-2024 ShareCast

AstraZeneca Regulatory News

1st Quarter Results 25-Apr-2024 07:00 RNS
Result of AGM 11-Apr-2024 17:30 RNS
AstraZeneca increases 2024 dividend by 7% 11-Apr-2024 07:00 RNS
Enhertu approved in US for HER2+ solid tumours 08-Apr-2024 07:00 RNS
Imfinzi improved OS & PFS in limited-stage SCLC 05-Apr-2024 07:00 RNS

AstraZeneca Newspaper Links

Proxy advisory groups under fire after AstraZene... 15-Apr-2024 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,026.00p
Change Today 674.00p
% Change 5.94 %
52 Week High 12,096.00
52 Week Low 9,501.00
Volume 4,120,393
Shares Issued 1,550.22m
Market Cap £186,430m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.69% below the market average91.69% below the market average91.69% below the market average91.69% below the market average91.69% below the market average
92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average
Price Trend
49.05% above the market average49.05% above the market average49.05% above the market average49.05% above the market average49.05% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
87.98% below the market average87.98% below the market average87.98% below the market average87.98% below the market average87.98% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
82.00% above the market average82.00% above the market average82.00% above the market average82.00% above the market average82.00% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 6
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 25-Apr-2024

Time Volume / Share Price
17:15 2,040 @ 11,967.56p
17:15 11,703 @ 11,993.06p
17:14 21,536 @ 12,025.52p
17:14 18,313 @ 12,025.52p
17:14 14,184 @ 11,975.24p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page